Yu SL - Search Results

1

Salvage Surgery for Advanced Lung Adenocarcinoma After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment.

Lin MW, Yu SL, Hsu YC, Chen YM, Lee YH, Hsiao YJ, Lin JW, Su TJ, Jeffrey Yang CF, Chiang XH, Hsu HH, Chen JS, Hsieh MS. Lin MW, et al. Among authors: yu sl. Ann Thorac Surg. 2023 Jul;116(1):111-119. doi: 10.1016/j.athoracsur.2023.01.027. Epub 2023 Feb 2. Ann Thorac Surg. 2023. PMID: 36739067

2

MicroRNA signature predicts survival and relapse in lung cancer.

Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJ, Yang PC. Yu SL, et al. Among authors: yu cj. Cancer Cell. 2008 Jan;13(1):48-57. doi: 10.1016/j.ccr.2007.12.008. Cancer Cell. 2008. PMID: 18167339 Free article.

3

Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.

Chang TP, Yu SL, Lin SY, Hsiao YJ, Chang GC, Yang PC, Chen JJ. Chang TP, et al. Among authors: yu sl. Cancer Res. 2010 Feb 15;70(4):1656-67. doi: 10.1158/0008-5472.CAN-09-2453. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145123

4

MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis.

Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, Tan CT, Lin MT, Kuo ML. Cha ST, et al. Among authors: yu sl. Cancer Res. 2010 Apr 1;70(7):2675-85. doi: 10.1158/0008-5472.CAN-09-2448. Epub 2010 Mar 16. Cancer Res. 2010. PMID: 20233879

5

Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.

Yuan A, Hsiao YJ, Chen HY, Chen HW, Ho CC, Chen YY, Liu YC, Hong TH, Yu SL, Chen JJ, Yang PC. Yuan A, et al. Among authors: yu sl. Sci Rep. 2015 Sep 24;5:14273. doi: 10.1038/srep14273. Sci Rep. 2015. PMID: 26399191 Free PMC article.

6

Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients.

Huang YH, Hsu KH, Tseng JS, Chen KC, Su KY, Chen HY, Chang CS, Chen JJ, Yu SL, Chen HW, Yang TY, Chang GC. Huang YH, et al. Among authors: yu sl. J Thorac Dis. 2016 Jan;8(1):86-92. doi: 10.3978/j.issn.2072-1439.2016.01.24. J Thorac Dis. 2016. PMID: 26904216 Free PMC article.

7

JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.

Chang WH, Ho BC, Hsiao YJ, Chen JS, Yeh CH, Chen HY, Chang GC, Su KY, Yu SL. Chang WH, et al. Among authors: yu sl. PLoS One. 2016 Mar 1;11(3):e0150355. doi: 10.1371/journal.pone.0150355. eCollection 2016. PLoS One. 2016. PMID: 26930648 Free PMC article.

8

SPANXA suppresses EMT by inhibiting c-JUN/SNAI2 signaling in lung adenocarcinoma.

Hsiao YJ, Su KY, Hsu YC, Chang GC, Chen JS, Chen HY, Hong QS, Hsu SC, Kang PH, Hsu CY, Ho BC, Yang TH, Wang CY, Jou YS, Yang PC, Yu SL. Hsiao YJ, et al. Among authors: yu sl. Oncotarget. 2016 Jul 12;7(28):44417-44429. doi: 10.18632/oncotarget.10088. Oncotarget. 2016. PMID: 27323831 Free PMC article.

9

Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma.

Su TJ, Ku WH, Chen HY, Hsu YC, Hong QS, Chang GC, Yu SL, Chen JJ. Su TJ, et al. Among authors: yu sl. Am J Cancer Res. 2016 Jun 1;6(6):1317-30. eCollection 2016. Am J Cancer Res. 2016. PMID: 27429846 Free PMC article.

10

Molecular gene signature and prognosis of non-small cell lung cancer.

Huang P, Cheng CL, Chang YH, Liu CH, Hsu YC, Chen JS, Chang GC, Ho BC, Su KY, Chen HY, Yu SL. Huang P, et al. Among authors: yu sl. Oncotarget. 2016 Aug 9;7(32):51898-51907. doi: 10.18632/oncotarget.10622. Oncotarget. 2016. PMID: 27437769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page